At the molecular level, the high-risk score group had elevated expressions of tumor enhancing factors, including MMP7 [51], and SFRP2 [52] (Fig. 3), which may synergistically promote tumor growth, proliferation, invasion and chemoresistance. The gene discussed is SFRP2; the disease is neoplasm.